Literature DB >> 436335

Heterogeneous neurocytotoxic antibodies in systemic lupus erythematosus.

H G Bluestein.   

Abstract

Sera from eighteen patients with systemic lupus erythematosus (SLE) were tested for cytotoxic antibody to three neuronal and two glial continuous cell lines of human origin. Eighty per cent (fifteen out of eighteen) of the sera were cytotoxic to at least one of the cell lines, but only seven sera were active against all five lines. Three sera had anti-neuronal but not anti-glial reactivity. No sera were gliocytotoxic without neurocytotoxicity. Three SLE sera with relatively strong cytotoxicity to all five cell lines were abosrbed with each of the cell lines separately and the absorbed sera were then tested for residual cytotoxicity to each of the cell lines. The absorptions uncovered at least six different antibody specificities directed at antigens expressed on some but not all of the neuronal and glial cell lines. Each patient's serum had its own profile of antibody specificities reactive with membrane antigens on nervous tissue-derived cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 436335      PMCID: PMC1537650     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Criteria for the classification of systemic lupus erythematosus--status 1972.

Authors:  A S Cohen; J J Canoso
Journal:  Arthritis Rheum       Date:  1972 Sep-Oct

2.  Definition of a continuous human cell line derived from neuroblastoma.

Authors:  J J Tumilowicz; W W Nichols; J J Cholon; A E Greene
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

3.  Antibody-mediated suppression of bone marrow colony formation in vitro.

Authors:  S Meyer-Hamme; H G Bluestein
Journal:  J Cell Physiol       Date:  1978-01       Impact factor: 6.384

4.  A naturally occurring antibody in New Zealand mice cytotoxic to dissociated cerebellar cells.

Authors:  R J Harbeck; A A Hoffman; S A Hoffman; D W Shucard; R I Carr
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

5.  Interspecies neural membrane antigens on cultured human and murine neuroblastoma cells.

Authors:  R Akeson; R C Seeger
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

6.  Adrenergic, cholinergic, and inactive human neuroblastoma cell lines with the action-potential Na+ ionophore.

Authors:  G J West; J Uki; H R Herschman; R C Seeger
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

7.  Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus.

Authors:  H G Bluestein
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

8.  Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement.

Authors:  B Bresnihan; M Oliver; R Grigor; G R Hughes
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

9.  Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines.

Authors:  R C Seeger; S A Rayner; A Banerjee; H Chung; W E Laug; H B Neustein; W F Benedict
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

10.  THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES.

Authors:  A E REIF; J M ALLEN
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

View more
  11 in total

1.  Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies.

Authors:  L T Costallat; R M de Oliveira; M B Santiago; W Cossermelli; A M Samara
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

2.  Beta2-glycoprotein I (beta2-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage.

Authors:  B Caronti; C Calderaro; C Alessandri; F Conti; R Tinghino; G Palladini; G Valesini
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 3.  Immunopathogenesis of the neuropsychiatric manifestations of systemic lupus erythematosus.

Authors:  H G Bluestein; K D Pischel; V L Woods
Journal:  Springer Semin Immunopathol       Date:  1986

4.  Clinical neurophysiology in the assessment of neurological symptoms in systemic lupus erythematosus.

Authors:  A B Mongey; D Glynn; M Hutchinson; B Bresnihan
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

Review 5.  Cerebral disease in systemic lupus erythematosus.

Authors:  E N Harris; G R Hughes
Journal:  Springer Semin Immunopathol       Date:  1985

6.  Biological activity of lymphocytotoxic antibodies in Graves' disease and Hashimoto's thyroiditis.

Authors:  W Pruzanski; H Capes; R Baur; B E Wenzel; V V Row; R Volpé
Journal:  J Endocrinol Invest       Date:  1984-02       Impact factor: 4.256

7.  Brain-reactive autoantibody levels in the sera of ageing autoimmune mice.

Authors:  S A Hoffman; D N Arbogast; P M Ford; D W Shucard; R J Harbeck
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

8.  Failure to detect brain reactivity of lymphocytotoxins in cerebral lupus.

Authors:  B A Pussell; F Blyth; J A Charlesworth
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

Review 9.  Diagnosis and pathogenesis of CNS lupus.

Authors:  A P van Dam
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

10.  Autoantibody to a novel neuronal antigen in systemic lupus erythematosus and in normal human sera.

Authors:  B h Toh; I R Mackay
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.